News Column

Massachusetts General Hospital Details Findings in Stem Cells (Treatment of Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem...

July 9, 2014



Massachusetts General Hospital Details Findings in Stem Cells (Treatment of Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation)

By a News Reporter-Staff News Editor at Biotech Week -- Investigators publish new report on Stem Cell Research. According to news reporting originating from Boston, Massachusetts, by NewsRx correspondents, research stated, "Disease relapse remains a major cause of mortality for patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (HSCT)."

Our news editors obtained a quote from the research from Massachusetts General Hospital, "Historically, patients who experience disease relapse after HSCT have a dismal prognosis with very few long-term survivors. There is no standard treatment for patients in this situation given the variability in patient characteristics, disease biology, complications such as graft-vs.-host disease (GVHD) and infections, donor availability, and patient choice."

According to the news editors, the research concluded: "Here, we discuss the current options for treatment of relapsed AML after HSCT including conventional chemotherapy, novel agents, donor leukocyte infusion, second allogeneic HSCT, and emerging therapies."

For more information on this research see: Treatment of Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Current Hematologic Malignancy Reports, 2014;9(2):186-192. Current Hematologic Malignancy Reports can be contacted at: Current Medicine Group, 400 Market Street, Ste 700, Philadelphia, PA 19106, USA. (Springer - www.springer.com; Current Hematologic Malignancy Reports - www.springerlink.com/content/1558-8211/)

The news editors report that additional information may be obtained by contacting A.T. Fathi, Massachusetts General Hospital, Bone Marrow Transplant Unit, Boston, MA 02114, United States (see also Stem Cell Research).

Keywords for this news article include: Boston, Surgery, Oncology, Hematology, Massachusetts, United States, Hematopoietic, Stem Cell Research, Cell Transplantation, Acute Myeloid Leukemia, North and Central America

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Biotech Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters